Journal profile · Medicine-Cardiology and Cardiovascular Medicine

ESC Heart Failure

ISSN 2055-5822 · The Heart Failure Association of the European Society of Cardiology · France

ESC Heart Failure: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.75; fully open access; APC charged, amount not published; median 119 days to acceptance (44 articles, last 24 months); 307 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.75Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time119 daysMedian, submission to acceptance · 44 articles, last 24 months · Crossref
APCCharged, amount not publishedFully open access
Acceptance—No reports yet
Articles per year3072025 · OpenAlex count

Scope

Aims, scope and focus

ESC Heart Failure is published by The Heart Failure Association of the European Society of Cardiology and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Cardiac pacing and defibrillation studies, together about 46.2% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

ESC Heart Failure is an official international, peer-reviewed journal of the Heart Failure Association (HFA), an association of the European Society of Cardiology (ESC). ESC Heart Failure is dedicated to the advancement of knowledge in the field of heart failure, including the understanding, prevention, investigation, and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline. Accordingly, the Journal welcomes submissions across basic, clinical and population sciences. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are clinical correspondence articles that highlight interesting aspects of heart failure care and treatment. Issues published per year: 6 Articles available: online only Access: fully open access Citation metrics Clarivate 2025 Impact Factor 3.8 2025 5 Year Impact Factor 3.7 Cardiac & Cardiovascular Systems (Rank by Impact Factor) 68/237 2025 Cited Half-Life 4 years 2025 Immediacy Index 1 2025 Eigenfactor Score 0.01987 2025 Article Influence Score 1.072 Scopus 2025 CiteScore 7.0 Cardiology And Cardiovascular Medicine (Rank by CiteScore) 69/409 About metrics Disclaimer Unless otherwise expressly indicated, statements of fact and opinion in the articles in ESC Heart Failure are those of the respective authors and contributors only and not of the Journal, the European Society of Cardiology, or Oxford University Press (OUP). Neither OUP, the European Society of Cardiology, nor the Journal make any representation, express or implied, in respect of the accuracy of the material in the Journal and have no legal responsibility or liability for any errors or omissions that may be made. Readers must make their own evaluation as to the appropriateness or otherwise of the information included.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Cardiology and Cardiovascular Medicine

Editor-in-chief Piotr PonikowskiPublisher website

Editorial board by country: none in mainland China; most named Germany 30, Italy 16, Poland 14, United States 10, Hungary 8 (117 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Heart Failure Treatment and ManagementMedicine22.9%
  2. Cardiovascular Function and Risk FactorsMedicine17.6%
  3. Cardiac pacing and defibrillation studiesMedicine5.6%
  4. Mechanical Circulatory Support DevicesEngineering5.1%
  5. Cardiac Structural Anomalies and RepairMedicine4.5%
  6. Cardiac Fibrosis and RemodelingMedicine3.4%
  7. Diabetes Treatment and ManagementMedicine3.3%
  8. Cardiovascular and exercise physiologyMedicine3.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorCardiac & Cardiovascular SystemsZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorCardiac & Cardiovascular SystemsZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorCardiac & Cardiovascular SystemsZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.75LetPub ·
Impact factor (publisher) 2025
3.8Publisher website ·
5-year impact factor (publisher) 2025
3.7Publisher website ·
CiteScore 2026-06
7LetPub ·
CiteScore (publisher) 2025
7Publisher website ·
SJR 2026-06
0.84LetPub ·
SNIP 2026-06
1.13LetPub ·
h-index
81OpenAlex ·
i10-index
1,888OpenAlex ·
2-year mean citedness
5.24OpenAlex ·
Self-citation rate
5.3%LetPub ·
Share of gold OA articles
99.91%LetPub ·

Volume

Articles per year
257LetPub ·

Articles by year OpenAlex count · 3,794 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026279279102
20253073071,076
20245475474,754
20233673674,361
20225085088,574
202160860812,130

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

119 daysMedian, submission to acceptance · P25–P75 76 days – 165 days

Acceptance to online
median 23 days (44 articles)
Submission to online
median 154 days
Sample
44 articles with submission and acceptance dates (702 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 12 weeksLetPub ·
Submission to publication (journal-reported)
about 10 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 4,788YesCC BY, CC BY-NC
OpenAlexUSD 4,850 / EUR 4,560 / GBP 3,250——
LetPubUSD 4,280 / GBP 2,870 / EUR 4,020Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteOpen access
Open access Open Access

OUP has Read and Publish agreements with institutions and consortia which provide funding for Open Access publication. This means authors from participating institutions can publish Open Access, and the institution will pay the charge. Find out if your institution is participating

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
The Heart Failure Association of the European Society of Cardiology
Country or region
France
Language
English
ISSN
2055-5822
Latest issue on the website
Volume 13, Issue 5 (October 2026)
Official links

FAQ

Frequently asked questions about ESC Heart Failure

What CAS zone is ESC Heart Failure in?

In the 2025 upgraded edition of the CAS Journal Ranking, ESC Heart Failure is in Zone 3 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of ESC Heart Failure?

The latest impact factor listed by LetPub is 3.75; CiteScore 7, h-index 81.

How long does peer review take at ESC Heart Failure?

Based on the dates recorded on 44 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 76–165 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of ESC Heart Failure based?

Of the 117 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (30), Italy (16) and Poland (14). Counted from the institutions listed on the board page; for reference only.

Which databases index ESC Heart Failure?

According to LetPub and DOAJ records, ESC Heart Failure is indexed in SCIE, Scopus and DOAJ.

Is ESC Heart Failure open access, and what is the APC?

ESC Heart Failure is a fully open-access journal. APC charged, amount not published.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .